Boehringer, Teva Want Aggrenox Pay-For-Delay Claims Nixed
Boehringer and Teva urged a Connecticut federal court on Wednesday to toss antitrust claims by Humana Inc., its employee health funds and other indirect purchasers of blood-clot medication Aggrenox in multidistrict...To view the full article, register now.
Already a subscriber? Click here to view full article